Background: Idiopathic anaphylaxis (IA) is a life-threatening disease. It is also a disease that is very often misdiagnosed. Before a diagnosis is established, the patient care costs can be exorbitant with regards to such things as emergency department visits and laboratory tests. In order to allow more patients to benefit from appropriate treatment, the medical community still needs to be better informed regarding this under-diagnosed disease. Method / data base: A review of the literature. Results and conclusion: Although the understanding of the initiating pathophysiology of IA is limited, it has proven to be a steroid responsive disease. It is also a disease that has a good prognosis for remission, in excess of 80%, with appropriate therapy.
ASJC Scopus subject areas
- Immunology and Allergy